BCL2 and type 2 diabetes mellitus: Along the same lines, expressions of proapoptotic markers (i.e., Caspase-3, Fas, and Bax-BCL2 Associated X) were significantly higher, while reduced expression of the antiapoptotic marker Bcl-2 (B-cell lymphoma 2) was observed in lymphocytes of T2DM patients [59].